Donders Institute for Brain, Cognition and Behaviour, Dept of Neurology, Radboud University Medical Center, Nijmegen, The Netherlands.
Dipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.
Eur Respir J. 2021 Nov 18;58(5). doi: 10.1183/13993003.00137-2021. Print 2021 Nov.
Respiratory muscle weakness is common in neuromuscular disorders (NMDs) and leads to significant respiratory difficulties. Therefore, reliable and easy assessment of respiratory muscle structure and function in NMDs is crucial. In the last decade, ultrasound and magnetic resonance imaging (MRI) have emerged as promising imaging techniques to assess respiratory muscle structure and function. Respiratory muscle imaging directly measures the respiratory muscles and, in contrast to pulmonary function testing, is independent of patient effort. This makes respiratory muscle imaging suitable to use as a tool in clinical respiratory management and as an outcome parameter in upcoming drug trials for NMDs, particularly in children. In this narrative review, we discuss the latest studies and technological developments in imaging of the respiratory muscles by ultrasound and MRI, and its clinical application and limitations. We aim to increase understanding of respiratory muscle imaging and facilitate its use as an outcome measure in daily practice and clinical trials.
呼吸肌无力在神经肌肉疾病(NMDs)中很常见,导致严重的呼吸困难。因此,可靠且易于评估 NMDs 中呼吸肌结构和功能至关重要。在过去的十年中,超声和磁共振成像(MRI)已成为评估呼吸肌结构和功能的有前途的成像技术。呼吸肌成像直接测量呼吸肌,与肺功能测试不同,它不依赖于患者的努力。这使得呼吸肌成像适合用作临床呼吸管理的工具,以及 NMD 即将进行的药物试验的结果参数,特别是在儿童中。在这篇叙述性综述中,我们讨论了超声和 MRI 对呼吸肌成像的最新研究和技术发展,以及其临床应用和局限性。我们旨在提高对呼吸肌成像的理解,并促进其在日常实践和临床试验中作为结果测量的应用。